Additionally, mutations in the filaggrin (FLG) gene, which affect 10–50% of AD patients, contribute to functional epidermal barrier defects with subsequent allergic sensitisation6–8, an increased incidence of skin infection, and increased risk for several allergies and/or allergic asthma9. Here, FLG is linked to skin infection.